CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Larotrectinib Sulfate

硫酸拉罗替尼 杂质对照品Larotrectinib Sulfate Impurities

22 个杂质条目22 impurity entries

本页汇总 硫酸拉罗替尼 的 22 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 22 impurity reference standards of Larotrectinib Sulfate. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

硫酸拉罗替尼 —— 原料药与杂质对照品Larotrectinib Sulfate — drug substance & impurities

共 22 个条目(含原料药本体)22 items incl. the drug substance
Larotrectinib Sulfate structure
原料药 APIAPI
硫酸拉罗替尼Larotrectinib Sulfate
Larotrectinib Sulfate
CAS No.1223405-08-0
Chemical FormulaC21H22F2N6O2·H2SO4
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib structure
—
拉罗替尼Larotrectinib
Larotrectinib
CAS No.1223403-58-4
Chemical FormulaC21H22F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 1 (Larotrectinib CNPP Impurity) structure
1
硫酸拉罗替尼杂质1 (拉罗替尼CNPP杂质)Larotrectinib Sulfate Impurity 1 (Larotrectinib CNPP Impurity)
Larotrectinib Sulfate Impurity 1 (Larotrectinib CNPP Impurity)
CAS No.1363380-51-1
Chemical FormulaC6H3ClN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Impurity 1 HCl structure
1
拉罗替尼杂质1Larotrectinib Impurity 1 HCl
Larotrectinib Impurity 1 HCl
CAS No.1443624-23-4
Chemical FormulaC10H12ClF2N
Purity>95%现货In stock
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 2 (Larotrectinib CPP Impurity) structure
2
硫酸拉罗替尼杂质2 (拉罗替尼CPP杂质)Larotrectinib Sulfate Impurity 2 (Larotrectinib CPP Impurity)
Larotrectinib Sulfate Impurity 2 (Larotrectinib CPP Impurity)
CAS No.29274-24-6
Chemical FormulaC6H4ClN3
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 3 (Larotrectinib DFP-PNPP Impurity) structure
3
硫酸拉罗替尼杂质3 (拉罗替尼DFP-PNPP杂质)Larotrectinib Sulfate Impurity 3 (Larotrectinib DFP-PNPP Impurity)
Larotrectinib Sulfate Impurity 3 (Larotrectinib DFP-PNPP Impurity)
CAS No.1223404-90-7
Chemical FormulaC16H13F2N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 4 (Larotrectinib DFP-PPP Impurity) structure
4
硫酸拉罗替尼杂质4 (拉罗替尼DFP-PPP杂质)Larotrectinib Sulfate Impurity 4 (Larotrectinib DFP-PPP Impurity)
Larotrectinib Sulfate Impurity 4 (Larotrectinib DFP-PPP Impurity)
CAS No.1223404-89-4
Chemical FormulaC16H14F2N4
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 5 (Larotrectinib DFP-PPPA Impurity) structure
5
硫酸拉罗替尼杂质5 (拉罗替尼DFP-PPPA杂质)Larotrectinib Sulfate Impurity 5 (Larotrectinib DFP-PPPA Impurity)
Larotrectinib Sulfate Impurity 5 (Larotrectinib DFP-PPPA Impurity)
CAS No.1223404-88-3
Chemical FormulaC16H15F2N5
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 6 (Larotrectinib PPO Impurity) structure
6
硫酸拉罗替尼杂质6 (拉罗替尼PPO杂质)Larotrectinib Sulfate Impurity 6 (Larotrectinib PPO Impurity)
Larotrectinib Sulfate Impurity 6 (Larotrectinib PPO Impurity)
CAS No.29274-22-4
Chemical FormulaC6H5N3O
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 7 (Larotrectinib Pyrrolidine Impurity) structure
7
硫酸拉罗替尼杂质7 (拉罗替尼吡咯烷杂质)Larotrectinib Sulfate Impurity 7 (Larotrectinib Pyrrolidine Impurity)
Larotrectinib Sulfate Impurity 7 (Larotrectinib Pyrrolidine Impurity)
CAS No.1218935-59-1
Chemical FormulaC10H11F2N
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 8 structure
8
硫酸拉罗替尼杂质8Larotrectinib Sulfate Impurity 8
Larotrectinib Sulfate Impurity 8
CAS No.1223404-68-9
Chemical FormulaC21H22F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 9 structure
9
硫酸拉罗替尼杂质9Larotrectinib Sulfate Impurity 9
Larotrectinib Sulfate Impurity 9
CAS No.2409590-08-3
Chemical FormulaC21H22F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 10 structure
10
硫酸拉罗替尼杂质10Larotrectinib Sulfate Impurity 10
Larotrectinib Sulfate Impurity 10
CAS No.2409589-59-7
Chemical FormulaC21H22F2N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 11 structure
11
硫酸拉罗替尼杂质11Larotrectinib Sulfate Impurity 11
Larotrectinib Sulfate Impurity 11
CAS No.1217630-38-0
Chemical FormulaC10H11F2N
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 12 structure
12
硫酸拉罗替尼杂质12Larotrectinib Sulfate Impurity 12
Larotrectinib Sulfate Impurity 12
CAS No.2541058-37-9
Chemical FormulaC10H11F2NO·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 13 structure
13
硫酸拉罗替尼杂质13Larotrectinib Sulfate Impurity 13
Larotrectinib Sulfate Impurity 13
CAS No.2825012-17-5
Chemical FormulaC6H3ClN4O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 16 structure
16
硫酸拉罗替尼杂质16Larotrectinib Sulfate Impurity 16
Larotrectinib Sulfate Impurity 16
CAS No.2840877-75-8
Chemical FormulaC16H13F2N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 17 structure
17
硫酸拉罗替尼杂质17Larotrectinib Sulfate Impurity 17
Larotrectinib Sulfate Impurity 17
CAS No.2819110-00-2
Chemical FormulaC16H15F2N5
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 18 structure
18
硫酸拉罗替尼杂质18Larotrectinib Sulfate Impurity 18
Larotrectinib Sulfate Impurity 18
CAS No.2135871-21-3
Chemical FormulaC23H19F2N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 19 structure
19
硫酸拉罗替尼杂质19Larotrectinib Sulfate Impurity 19
Larotrectinib Sulfate Impurity 19
CAS No.2937977-82-5
Chemical FormulaC23H19F2N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 22 structure
22
硫酸拉罗替尼杂质22Larotrectinib Sulfate Impurity 22
Larotrectinib Sulfate Impurity 22
CAS No.3040394-58-6
Chemical FormulaC33H28F4N10O
Purity>95%询价On request
10mg25mg50mg100mg
Larotrectinib Sulfate Impurity 23 structure
23
硫酸拉罗替尼杂质23Larotrectinib Sulfate Impurity 23
Larotrectinib Sulfate Impurity 23
CAS No.3041064-67-6
Chemical FormulaC25H31F2N7O3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

For formulation & analytical R&D

硫酸拉罗替尼 杂质谱研究要点Larotrectinib Sulfate — impurity profiling notes

下面这些是拿到 硫酸拉罗替尼 的 22 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 22 impurity entries for Larotrectinib Sulfate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances